bluuebunny/crossref_metadata_2025_split huggingface dataset:
Comparative Analysis Of Humanization Present In Nursing Assistance Between Brazil And New York: A Lived Experience
Authors: Evangelista Bianka Pereira , Nunes Elicarlos Marques , Barreto Ana Paula Suassuna Veras , Sousa Andréia Rayanne Queroz de , Santos Francisca Lima dos , Oliveira Jordeyanne Ferreira de , Alves Karine Lucena , Lima Mariana Brilhante de , Nogueira Tariana Rodrigues , Nobre Juliane De Oliveira Costa , Martins Edmara Da Nóbrega Xavier , Barbosa Ana Beatriz Alves , Leite Kamila Nethielly Souza , Silva Sheila Da Costa Rodrigues , Ferreira Allan Martins 
Published: April 2017

Objetive: The study is an experience report, with the objective of reporting differences in the humanization present in nursing care between a Brazilian city and two cities of the United States of America, highlighting the potentialities and fragility of care provided in both cities frequented by students of Patos Integrated College - FIP.
Method: The study was based on the exchange linked to the Bounce project, funded by the US government, which took place between May 21 and June 20, 2015, and was attended by 8 (eight) FIP scholars from Paraíba, Brazil. Through the study it was possible to perform a comparative analysis between the Brazilian hospital reality, seen in the FIP curriculum internship field, through the Deputy Janduhy Carneiro Regional Hospital, located in the municipality of Patos - Paraíba, Brazil, and the North American, evidenced by the visit to the hospitals of Hudson and New Paltz.
Results: It was observed that the difference in care is in the humanization present in the Brazilian nursing care process. It is noteworthy the great work done by these professionals, who are not only concerned with technical-scientific efficiency, but with humanized assistance, based on ethical, moral, affection and for mutual respect precepts. Comparing the assistance provided in the two realities, we observed in our country a predominantly humanistic, rather than mechanical, assistance. Therefore, it is concluded that it is fundamental to seek tools that improve our Health System, consequently, providing benefits both for professionals, as well as for the users assisted.
Conclusion: In this way, it can be said that humanization does not depend only on technological resources to be shared.
Keywords: Nursing care. Humanization. Hospital.
Removal of artificial dental calculus by use of conventional and diamond ultrasound tips.
Authors: Pinho Roberto Carlos Mourão , Amorim Fernanda Benevides Viana de , Tenório Quitéria Maria Wanderley Albuquerque , Pegoraro Thiago Amadei , Penteado Luiz Alexandre Moura , Cimões Renata 
Published: April 2017

Introduction: Periodontal disease is considered a public health problem and may lead to serious complications as the general health of patient. The main therapeutic procedure is scaling and root planing, which can be performed by a variety of techniques and instruments
Objective:The aim of the present study was to evaluate the removal of calculus, produced artificially, by using a conventional ultrasonic tip and a diamond – CVD tip.
Method: The calculus was produced with artificial sawdust and glue-based cyanoacrylate and distributed in twenty areas also standardized on two plates of acrylic resin (chemical activated), holding 10 samples per plate. Standards / samples were divided by lot into two simple groups, being A (treated with conventional tip) and B (treated with CVD tip).
Results:The treatment in Group A, promoted an average area of 20.48 ± 4.20 mm2 free of artificial calculus which is significantly higher (p <0.05) than the area removed in Group B (15.37 ± 5.29 mm2).
Conclusion:The results showed that the conventional tip presented higher results than CVD tip for efficacy in the removal of calculus.
Integral Health Care As A Guiding Axis Of Medical Training: Case Studies
Authors: De Lima Neto Alcides Viana , Teixeira Elisangela Medeiros , Cortez de Sena Bruna Aderita , De Araújo Neves Naedja Nara , Albuquerque Ribeiro Lariane Thays , Santos Fernandes Aline Samaya , De Araújo Nunes Vilani Medeiros , Lisboa Maia Damiao Karla Simone , Freitas Lemos Ana Priscila , Barros Rafael Pontes 
Published: April 2017

Objective: The aim is to report the experiences during the practical experiences in the territory assigned to a basic health unit provided by the module of Integral Health Care I.
Methods: Case studies resulting from a process of critical reflections about practical experiences by medical students in a basic health unit from August to December 2015.
Results: Through the module of Integral Health Care I, students were allowed to recognize the assigned area of a family health team, as well as to develop the territorialization process and to classify the demographic, epidemiological, socioeconomic and environmental profile in that place; in addition to perform other activities as a singular therapeutic project and intervention project.
Conclusion: The activities developed motivated the students to be able to apply the concepts of family and community medicine in primary health care, in addition to bringing them closer to the reality of this work process.
Descriptors: Integral Health Care; Family Health Strategy; Physician-Patient Relationship; Basic Health Unit.
Frailty Assessment and its Association with Sociodemographic and Health Characteristics in Community Elderly
Authors: Maciel Graciela Maria Carneiro , Silva Heloiza Talita Adriano da , Gonçalves Rafaella Guilherme , Ferreira Josefa Danielma Lopes , Tietre Sarah Vinagre , Menezes Rejane Maria Paiva de 
Published: April 2017

Background: Frailty assessment in the elderly and its relationship to sociodemographic and health characteristics.
Method: Quantitative study, descriptive and cross-sectional study, conducted between April to July 2014, at two Family Health Units in Natal, Rio Grande do Norte. The sample consisted of 203 elderly. The data collection procedure occurred through a structured interview, which used two instruments.
Results: The average age of the participants was 68.59 years; among them, 83 (40.89%) did not show weakness, 45 (22.17%) were apparently vulnerable and 75 (36.94%) were frail. The weakness associated with low education, widowhood, heart disease, diabetes mellitus, osteoporosis, respiratory disease, urinary tract infection, depression, six classes of drugs (antidiabetic, antidepressant, anxiolytic, and antacid against osteoporosis) and fall episode.
Conclusions: We conclude that assessment of frailty is important to detect the risk and/or embrittlement process already installed in the elderly.
Paleolimnological assessment of nutrient enrichment on diatom assemblages in a priori defined nitrogen- and phosphorus-limited lakes downwind of the Athabasca Oil Sands, Canada
Authors: Laird Kathleen R. , Das Biplob , Hesjedal Brittany , Leavitt Peter R. , Mushet Graham R. , Scott Kenneth A. , Simpson Gavin L. , Wissel Bjorn , Wolfe Jared , Cumming Brian F. 
Published: April 2017

<p>As the industrial footprint of the Athabasca Oil Sands Region (AOSR) continues to expand, concern about the potential impacts of pollutants on the surrounding terrestrial and aquatic ecosystems need to be assessed. An emerging issue is whether recent increases in lake production downwind of the development can be linked to AOSR activities, and/or whether changing climatic conditions are influencing lake nutrient status. To decipher the importance of pollutants, particularly atmospheric deposition of reactive nitrogen (Nr), and the effects of climate change as potential sources of increasing lake production, lakes from both within and outside of the nitrogen deposition zone were analyzed for historical changes in diatom assemblages. Lake sediment cores were collected from <em>a priori</em> defined nitrogen (N) - and phosphorus (P) - limited lakes within and outside the N plume associated with the AOSR. Diatom assemblages were quantified at sub-decadal resolution since ca. 1890 to compare conditions prior to oil sands expansion and regional climate warming, to the more recent conditions in each group of lakes (Reference and Impacted, N- and P-limited lakes). Analyses of changes in assemblage similarity and species turnover indicates that changes in diatom assemblages were minimal both within and across all lake groups. Small changes in percent composition of planktonic taxa, particularly small centric taxa (<em>Discostella </em>and <em>Cyclotella</em> species) and pennate taxa, such as <em>Asterionella formosa</em> and <em>Fragilaria crotonensis</em>, occurred in some of the lakes. While these changes were consistent with potential climate effects on algal growth, water column stability and other factors; the timing and direction of biotic changes were variable among sites suggesting that any apparent response to climate was lake dependent. The absence of a consistent pattern of diatom changes associated with receipt of reactive nitrogen or intrinsic nutrient-limitation status of the lake suggest that downwind AOSR emissions had no demonstrable effect on diatom composition. </p>
Locality Restrictions on N-Word Licensing
Authors: Omari Naima 
Published: April 2017

The main objective of this paper is to consider the locality restrictions that hold between Negation and N(egative)-words within the framework of the Minimalist Program. The discussions are based on data from Amazigh, in particular the Tashelhit variety spoken in the Southwest of Morocco. By N-words, I intend elements like ‘ħtta+NP’ ( no-one) which are licensed by the negative head ‘ur’. In the suggested analysis, I show that certain tense- related restrictions as well as island-like locality constraints affect the surface distribution of N-words. I also argue that sensitivity to such locality constraints cannot be accounted for in terms of constraints on movement; rather, it is a property of the chain formed by the negative head and the N-word in- situ.
Hodgkin Disease/Lymphoma Clinical Practice Guidelines
Authors: _ _ 
Published: April 2017

Cure rates for Hodgkin disease/lymphoma have increased to such an extent that the overriding treatment considerations often relate to long-term toxicity, especially for patients with early- or intermediate-stage disease. Current management programs are based on comprehensive clinical staging followed by combined modality therapy for patients with favorable and intermediate prognosis, or chemotherapy alone for patients with advanced disease. Relapse is uncommon, but secondary management with peripheral stem cell transplantation may be effective. The excellent prognosis for these patients mandates careful long-term follow-up to detect late treatment effects.
For the most recent version of the guidelines, please visit NCCN.org
Esophageal Cancer Clinical Practice Guidelines
Authors: _ _ 
Published: April 2017

Carcinomas originating in the upper gastrointestinal (GI) tract (esophagus, gastroesophageal junction, and stomach) constitute a worldwide major health problem. Unfortunately, esophageal carcinoma is often diagnosed late, and most therapeutic approaches are palliative, although advances have been made in staging procedures and therapy. The guidelines emphasize that palpable advances have been made in the treatment of locoregional esophageal carcinoma. Similarly, endoscopic palliation of esophageal carcinoma has improved substantially because of improving technology.
For the most recent version of the guidelines, please visit NCCN.org
Gastric Cancer Clinical Practice Guidelines
Authors: _ _ 
Published: April 2017

Gastric carcinoma is rampant in many countries around the world. An estimated 36,380 new cases of upper GI carcinomas and 25,120 deaths from these tumors will occur in the United States in 2005. These guidelines provide a systematic approach to gastric cancer and discuss advances in staging procedures such as laparoscopy and endoscopic ultrasonography and in possible functional imaging techniques. The guidelines also discuss the new standard in the United States: combination chemotherapy and radiotherapy in the adjuvant setting for a select group of patients.
For the most recent version of the guidelines, please visit NCCN.org
Uterine Cancers Clinical Practice Guidelines
Authors: _ _ 
Published: April 2017

Adenocarcinoma of the endometrium is the most common malignancy of the female genital tract in the United States. Many physicians believe that adenocarcinoma of the endometrium is a relatively benign disease because of the early symptoms of irregular vaginal bleeding in this predominantly postmenopausal patient population, the often-localized nature of the disease, and the generally high survival rate. However, the estimated number of deaths from endometrial cancer continues to increase, indicating the need for a critical reassessment of the guidelines for managing endometrial cancer. Physicians must identify high-risk patients and tailor treatment appropriately to provide the best opportunity for long-term survival.
For the most recent version of the guidelines, please visit NCCN.org
Hepatobiliary Cancers
Authors: _ _ 
Published: April 2017

Hepatobiliary cancers are common worldwide and highly lethal. Hepatocellular carcinoma is the most common hepatobiliary malignancy and the seventh most common cancer worldwide. Gallbladder cancer is the most common biliary tract malignancy, accounting for approximately 5000 newly diagnosed cases in the United States. Cholangiocarcinomas are diagnosed throughout the biliary tree and are usually classified as intrahepatic or extrahepatic. Intrahepatic cholangiocarcinomas arise from intrahepatic small-duct radicals, whereas extrahepatic cholangiocarcinomas encompass hilar carcinomas (including Klatskin's tumors). These guidelines discuss these subtypes of hepatobiliary cancer and the epidemiology, pathology, etiology, staging, diagnosis, and treatment of each subtype.
For the most recent version of the guidelines, please visit NCCN.org
Antiemesis
Authors: _ _ 
Published: April 2017

Chemotherapy-induced nausea and vomiting (emesis) can significantly affect a patient's quality of life, leading to poor adherence with further chemotherapy treatment. In addition, nausea and vomiting can result in other serious complications and deterioration of the patient's status. These guidelines explore the prevention, treatment, and management of various types of emesis experienced by cancer patients, such as breakthrough, radiation-induced, and anticipatory.
For the most recent version of the guidelines, please visit NCCN.org
Soft Tissue Sarcoma Guidelines
Authors: _ _ 
Published: April 2017

Soft tissue sarcomas are the most frequent sarcomas; the annual incidence for 2007 in the United States is estimated at about 9220 cases, with an overall mortality rate of approximately 3560 cases per year. Important updates for the 2007 version of the guidelines include the addition of epirubicin (single agent) and the combination of epirubicin, ifosfamide, and mesna as generally accepted systemic therapy. Imatinib was added as an option for desmoid tumors.
For the most recent version of the guidelines, please visit NCCN.org
Chronic Myelogenous Leukemia Guidelines
Authors: _ _ 
Published: April 2017

Chronic myelogenous leukemia (CML) accounts for 15% of adult leukemias. In 2007, an estimated 4500 cases will be diagnosed and 900 patients will die of the disease. The goal of CML therapy is complete remission, which typically progresses from hematologic to cytogenetic remission. These updated 2007 guidelines include changes to several treatment recommendations, including considerations for imatinib dosing, the use of interferon, and management of dasatinib toxicity. Recommendations for hematopoetic stem cell transplantation have also been updated.
For the most recent version of the guidelines, please visit NCCN.org
Basal Cell and Squamous Cell Skin Cancers Guidelines
Authors: _ _ 
Published: April 2017

Basal cell and squamous cell skin cancers, collectively known as non-melanoma skin cancers (NMSCS), are the most common skin cancers. More than 1 million cases of NMSC are estimated to be diagnosed each year in the United States and their incidence is rising rapidly. Although rarely metastatic, basal cell and squamous cell cancers can produce substantial local destruction and disfigurement and may involve extensive areas of soft tissue, cartilage, and bone. Updates in the 2007 guidelines include changes to the principles of treatment for both basal cell and squamous cell skin cancers and changes in the consideration of radiotherapy.
For the most recent version of the guidelines, please visit NCCN.org
Dermatofibrosarcoma Protuberans Guidelines
Authors: _ _ 
Published: April 2017

Dermatofibrosarcoma protuberans (DFSP) is an uncommon, low-grade sarcoma of fibroblast origin with an incidence rate of 0.8 cases per million persons each year. Although it rarely metastasizes, initial misdiagnosis, prolonged time to accurate diagnosis, and large tumor size at diagnosis are common. These updated 2007 guidelines include changes in recommendations for considering radiation therapy, as well as those regarding surgical margins in some patients.
For the most recent version of the guidelines, please visit NCCN.org
Prostate Cancer
Authors: _ _ 
Published: April 2017

To properly identify and treat patients with prostate cancer, physicians must have an in-depth understanding of the natural history and diagnostic, staging, and treatment options. Prostate cancer is a complex disease, with many controversial aspects of management and a dearth of sound data to support recommendations. Several variables must be considered in tailoring prostate cancer therapy to each individual patient. These guidelines provide a framework on which to base treatment decisions. Important changes to the guidelines since last publication include the introduction of Principles of Life Expectancy Estimation table and changes in recommendations for both hormone and chemotherapy.
For the most recent version of the guidelines, please visit NCCN.org
Breast Risk Reduction
Authors: _ _ 
Published: April 2017

Breast cancer is the most commonly diagnosed cancer in American women, with an estimated 214,640 cases and 41,430 deaths occurring in 2006. Estimating breast cancer risk for individual women is difficult, and most breast cancers are not attributable to risk factors other than female gender and increased age. Developing effective strategies for reducing breast cancer incidence is also difficult because few existing risk factors are modifiable and some potentially modifiable risk factors have social implications. Nevertheless, effective breast cancer risk reduction agents and strategies, such as tamoxifen, raloxifene, and risk reduction surgery, have been identified. These guidelines were developed to help women at increased risk for breast cancer and their physicians apply individualized strategies to reduce breast cancer risk.
For the most recent version of the guidelines, please visit NCCN.org
Colon Cancer
Authors: _ _ 
Published: April 2017

Colorectal cancer is the third most frequently diagnosed cancer in men and women in the United States. An estimated 112,340 new cases of colon cancer will occur in 2007 and an estimated 52,180 people will die from colon and rectal cancer in the same year. Despite these statistics, mortality from colon cancer has decreased over the past 30 years, possibly because of earlier diagnosis through screening and better treatment modalities. These guidelines begin with the clinical presentation of the patient to the primary care physician or gastroenterologist and address diagnosis, pathologic staging, surgical management, adjuvant treatment, management of recurrent and metastatic disease, and patient surveillance.
For the most recent version of the guidelines, please visit NCCN.org
Pancreatic Adenocarcinoma
Authors: _ _ 
Published: April 2017

An estimated 33,370 people will die of pancreatic cancer in the United States in 2007, making it the fourth most common cause of cancer-related death among men in the United States. Although incidence is roughly equal among men and women, African Americans appear to have a higher incidence of pancreatic cancer than white Americans. The NCCN Pancreatic Adenocarcinoma Guidelines discuss risk factors, diagnosis and staging, and treatment through palliative care or surveillance for patients with tumors of the exocrine pancreas. Overall, in view of the poor outcome of patients with all stages of pancreatic cancer, the NCCN panel recommends that investigational options be considered in all phases of disease management. Specific palliative measures are recommended for patients with advanced pancreatic adenocarcinoma characterized by biliary or gastric obstruction, severe abdominal pain, or other tumor-associated manifestations of the disease.
For the most recent version of the guidelines, please visit NCCN.org
Prevention and Treatment of Cancer-Related Infections
Authors: _ _ 
Published: April 2017

Infectious diseases are important causes of morbidity and mortality in patients with cancer. In certain instances, the malignancy itself can predispose patients to severe or recurrent infections. Neutropenia has been recognized for many decades as a major risk factor, and effective strategies to anticipate, prevent, and manage infectious complications in patients with cancer experiencing neutropenia have led to improved outcomes. Reflecting the heterogeneity of immunocompromised conditions in patients with cancer and the spectrum of pathogens to which they are susceptible, NCCN expanded the scope of the Fever and Neutropenia Panel in 2007 to create guidelines on Prevention and Treatment of Cancer-Related Infections. These guidelines, newly updated for 2008, characterize major categories of immunologic deficits in persons with cancer and the major pathogens to which they are susceptible.
For the most recent version of the guidelines, please visit NCCN.org
Cancer- and Chemotherapy-Induced Anemia
Authors: _ _ 
Published: April 2017

Anemia is a common condition in patients with cancer, and its correction through either transfusion with packed red blood cells or the administration of erythropoiesis-stimulating agents (ESAs) is a supportive care measure. The purpose of the guidelines is to operationalize the evaluation and treatment of anemia in cancer patients and to enable patients and clinicians to evaluate treatment options in the context of risks and benefits. The updated guidelines include a number of important changes that respond to new FDA recommendations limiting the use of ESAs in cancer patients. Updates also include new tables on the risks and benefits of ESAs versus red blood cell transfusion and recommendations for administering parenteral iron products.
For the most recent version of the guidelines, please visit NCCN.org
Hodgkin Disease/Lymphoma
Authors: _ _ 
Published: April 2017

Hodgkin disease/lymphoma (HD/HL) is an uncommon malignancy; in 2008, an estimated 8220 new diagnoses and 1350 deaths will occur in the United States. The past few decades have seen significant progress in the management of HL; it is now curable in at least 80% of patients. In fact, cure rates for HL have increased so extensively that the overriding treatment considerations often relate to long-term toxicity, especially for patients with early- or intermediate-stage disease. The World Health Organization classification divides HL into 2 main types: classical and lymphocyte-predominant HL (CHL and LPHL). These guidelines discuss clinical management, focusing exclusively on patients from postadolescence through the seventh decade of life who do not have serious intercurrent disease.
For the most recent version of the guidelines, please visit NCCN.org